A detailed history of Oppenheimer & CO Inc transactions in Tekla Healthcare Investors stock. As of the latest transaction made, Oppenheimer & CO Inc holds 113,387 shares of HQH stock, worth $1.98 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
113,387
Previous 97,069 16.81%
Holding current value
$1.98 Million
Previous $1.61 Million 18.84%
% of portfolio
0.03%
Previous 0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$16.46 - $17.44 $268,594 - $284,585
16,318 Added 16.81%
113,387 $1.91 Million
Q4 2023

Feb 13, 2024

BUY
$14.32 - $16.57 $211,320 - $244,523
14,757 Added 17.93%
97,069 $1.61 Million
Q3 2023

Nov 07, 2023

BUY
$15.52 - $17.49 $24,304 - $27,389
1,566 Added 1.94%
82,312 $1.28 Million
Q2 2023

Aug 02, 2023

BUY
$16.52 - $17.9 $68,310 - $74,016
4,135 Added 5.4%
80,746 $1.38 Million
Q1 2023

May 10, 2023

BUY
$16.86 - $19.02 $15,342 - $17,308
910 Added 1.2%
76,611 $1.35 Million
Q4 2022

Feb 07, 2023

SELL
$17.4 - $19.47 $11,657 - $13,044
-670 Reduced 0.88%
75,701 $1.36 Million
Q3 2022

Nov 14, 2022

BUY
$17.08 - $20.71 $114,367 - $138,674
6,696 Added 9.61%
76,371 $1.32 Million
Q2 2022

Aug 08, 2022

BUY
$17.53 - $21.84 $18,073 - $22,517
1,031 Added 1.5%
69,675 $1.3 Million
Q1 2022

May 12, 2022

BUY
$18.93 - $24.02 $10,260 - $13,018
542 Added 0.8%
68,644 $1.43 Million
Q4 2021

Feb 02, 2022

BUY
$22.75 - $26.5 $297,820 - $346,911
13,091 Added 23.8%
68,102 $1.62 Million
Q3 2021

Nov 12, 2021

SELL
$25.11 - $27.93 $382,701 - $425,681
-15,241 Reduced 21.69%
55,011 $1.41 Million
Q2 2021

Aug 03, 2021

BUY
$23.09 - $25.91 $43,755 - $49,099
1,895 Added 2.77%
70,252 $1.81 Million
Q1 2021

May 10, 2021

BUY
$22.8 - $25.84 $101,049 - $114,522
4,432 Added 6.93%
68,357 $1.67 Million
Q4 2020

Feb 11, 2021

BUY
$19.72 - $23.83 $101,991 - $123,248
5,172 Added 8.8%
63,925 $1.52 Million
Q3 2020

Nov 13, 2020

SELL
$19.71 - $22.33 $9,697 - $10,986
-492 Reduced 0.83%
58,753 $1.21 Million
Q2 2020

Aug 11, 2020

BUY
$16.98 - $21.6 $219,602 - $279,352
12,933 Added 27.93%
59,245 $1.26 Million
Q1 2020

May 08, 2020

SELL
$14.77 - $21.66 $14,873 - $21,811
-1,007 Reduced 2.13%
46,312 $824,000
Q4 2019

Feb 07, 2020

BUY
$17.86 - $21.36 $20,610 - $24,649
1,154 Added 2.5%
47,319 $988,000
Q3 2019

Oct 31, 2019

SELL
$18.24 - $20.34 $85,691 - $95,557
-4,698 Reduced 9.24%
46,165 $847,000
Q2 2019

Aug 09, 2019

BUY
$18.85 - $20.79 $46,748 - $51,559
2,480 Added 5.13%
50,863 $1.02 Million
Q1 2019

Apr 24, 2019

BUY
$18.39 - $21.16 $17,323 - $19,932
942 Added 1.99%
48,383 $994,000
Q4 2018

Jan 29, 2019

BUY
$16.57 - $23.12 $22,253 - $31,050
1,343 Added 2.91%
47,441 $852,000
Q3 2018

Oct 26, 2018

SELL
$21.53 - $23.25 $23,101 - $24,947
-1,073 Reduced 2.27%
46,098 $1.07 Million
Q2 2018

Aug 10, 2018

BUY
$20.46 - $22.21 $53,727 - $58,323
2,626 Added 5.9%
47,171 $1.01 Million
Q1 2018

May 01, 2018

SELL
$21.28 - $24.62 $19,003 - $21,985
-893 Reduced 1.97%
44,545 $959,000
Q4 2017

Feb 07, 2018

SELL
$21.77 - $25.76 $4,571 - $5,409
-210 Reduced 0.46%
45,438 $1.03 Million
Q3 2017

Nov 09, 2017

BUY
$23.83 - $25.73 $1.09 Million - $1.17 Million
45,648
45,648 $1.15 Million

Others Institutions Holding HQH

About TEKLA HEALTHCARE INVESTORS


  • Ticker HQH
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund prim...
More about HQH
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.